Dianthus Therapeutics DNTH Cash Flow Statement
| Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | ||
|---|---|---|---|---|---|---|
| -$40.83M-38.4% | -$36.77M-46.0% | -$31.63M-79.6% | -$29.51M-115% | -$28.44M-169% | ||
| $32K+18.5% | $27K+8.0% | $30K+30.4% | $27K+22.7% | $26K+30.0% | ||
| $10.6M+99.5% | $5.79M+50.9% | $5.71M+84.0% | $5.32M+161% | $3.92M+440% | ||
| -$28.86M-4.4% | -$30.56M-43.7% | -$23.89M-64.5% | -$27.63M-84.9% | -$27.44M-132% | ||
| $10K-58.3% | $5K-80.0% | $46K+171% | $24K-25.0% | $31K+210% | ||
| -$133.97M-1,006% | -$201.28M+22.4% | $26.45M— | $14.79M+369% | -$23.11M— | ||
| $739.41M+459,161% | $274.51M+92,641% | $568K— | $161K-99.9% | $39.68M— | ||
| $576.58M+4,649% | $42.68M+115% | —— | -$12.68M-106% | -$10.88M— | ||
| -$28.87M-4.4% | -$30.56M-43.5% | -$23.94M-64.6% | -$27.65M-84.7% | -$27.48M-132% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Dianthus Therapeutics generate?
- Dianthus Therapeutics (DNTH) generated -$110.9M in operating cash flow over the trailing twelve months.
- What is Dianthus Therapeutics's free cash flow?
- After $85.0K of capital expenditures, Dianthus Therapeutics's free cash flow was -$111.0M over the trailing twelve months, down 41.8% year over year.
- Where does Dianthus Therapeutics's cash flow data come from?
- Every line is extracted from Dianthus Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.